IDEXX Laboratories, Inc. (IDXX) Earnings History
Growth Compounder35 years of earnings data (1991–2025) · Consistent double-digit EPS growth over 5 years
Loading earnings history...
IDEXX Laboratories, Inc. (IDXX) Earnings Overview
As of June 22, 2026, IDEXX Laboratories, Inc. (IDXX) reported trailing twelve-month net income of $1.10B, reflecting +22.6% year-over-year growth. The company earned $13.58 per diluted share over the past four quarters, with a net profit margin of 24.6%.
Looking at the long-term picture, IDXX's 5-year EPS compound annual growth rate (CAGR) stands at +14.3%, showing solid earnings momentum. The company achieved its highest annual net income of $1.06B in fiscal 2025, representing a new all-time high.
IDEXX Laboratories, Inc. maintains industry-leading profitability with a gross margin of 61.8%, operating margin of 31.6%, and net margin of 24.6%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ZTS ($2.64B net income, 28.2% margin), HSIC ($398M net income, 3.0% margin), ELAN (-$242M net income, -4.9% margin), IDXX has room to improve margins relative to the peer group. Compare IDXX vs ZTS →
IDXX Earnings vs Peers
Earnings metrics vs comparable public companies
IDXX Historical Earnings Data (1991–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.06B | +19.3% | $1.36B | $13.08 | 24.6% | 31.6% |
| 2024 | $888M | +5.1% | $1.13B | $10.67 | 22.8% | 29.0% |
| 2023 | $845M | +24.4% | $1.10B | $10.06 | 23.1% | 30.0% |
| 2022 | $679M | -8.8% | $899M | $8.03 | 20.2% | 26.7% |
| 2021 | $745M | +28.0% | $932M | $8.60 | 23.2% | 29.0% |
| 2020 | $582M | +36.0% | $695M | $6.71 | 21.5% | 25.7% |
| 2019 | $428M | +13.4% | $553M | $4.89 | 17.8% | 23.0% |
| 2018 | $377M | +43.3% | $491M | $4.26 | 17.0% | 22.2% |
| 2017 | $263M | +18.5% | $413M | $2.94 | 13.4% | 21.0% |
| 2016 | $222M | +15.6% | $350M | $2.44 | 12.5% | 19.7% |
| 2015 | $192M | +5.6% | $300M | $2.05 | 12.0% | 18.7% |
| 2014 | $182M | -3.1% | $260M | $1.79 | 12.2% | 17.5% |
| 2013 | $188M | +5.3% | $267M | $1.74 | 13.6% | 19.4% |
| 2012 | $178M | +10.2% | $263M | $1.59 | 13.8% | 20.3% |
| 2011 | $162M | +14.5% | $236M | $1.39 | 13.3% | 19.4% |
| 2010 | $141M | +15.6% | $204M | $1.19 | 12.8% | 18.5% |
| 2009 | $122M | +5.2% | $176M | $1.00 | 11.8% | 17.1% |
| 2008 | $116M | +23.6% | $172M | $0.94 | 11.3% | 16.8% |
| 2007 | $94M | +0.4% | $136M | $0.73 | 10.2% | 14.8% |
| 2006 | $94M | +19.7% | $128M | $0.71 | 12.7% | 17.3% |
| 2005 | $78M | -0.1% | $115M | $0.57 | 12.3% | 18.1% |
| 2004 | $78M | +37.2% | $108M | $0.55 | 14.3% | 19.7% |
| 2003 | $57M | +25.8% | $80M | $0.40 | 12.0% | 16.9% |
| 2002 | $45M | +20.7% | $66M | $0.33 | 11.0% | 15.9% |
| 2001 | $38M | +2.7% | $57M | $0.27 | 9.7% | 14.6% |
| 2000 | $37M | +12.4% | $53M | $0.26 | 10.0% | 14.5% |
| 1999 | $33M | +314.5% | $47M | $0.21 | 9.2% | 13.1% |
| 1998 | -$15M | +28.0% | $29M | $-0.10 | -4.8% | 9.1% |
| 1997 | -$21M | -164.7% | -$4M | $-0.14 | -8.0% | -1.7% |
| 1996 | $33M | +51.6% | $47M | $0.21 | 12.2% | 17.6% |
| 1995 | $22M | +61.7% | $33M | $0.15 | 11.4% | 17.4% |
| 1994 | $13M | +37.1% | $23M | $0.10 | 10.5% | 18.0% |
| 1993 | $10M | +98.0% | $14M | $0.07 | 10.4% | 14.9% |
| 1992 | $5M | +53.1% | $5M | $0.04 | 8.5% | 8.8% |
| 1991 | $3M | - | $3M | $0.04 | 10.5% | 8.5% |
Download Data
Export IDXX earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into IDXX consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
35+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IDXX — Frequently Asked Questions
Quick answers to the most common questions about buying IDXX stock.
What is IDXX earnings per share (EPS)?
IDXX trailing twelve-month (TTM) diluted EPS is $13.58, reflecting +22.6% year-over-year growth. The 5-year EPS CAGR is +14.3%. Complete EPS history from 1991 to 2025 is available in the table on this page.
What is IDEXX Laboratories, Inc.'s net income?
IDEXX Laboratories, Inc. (IDXX) trailing twelve-month net income is $1.1B as of 2025. Earnings grew +22.6% year-over-year. IDEXX Laboratories, Inc. has been profitable for 27 consecutive years.
Is IDXX profitable?
Yes, IDXX is profitable with a TTM net income of $1.1B and a net profit margin of +24.6%. IDEXX Laboratories, Inc. has generated profits for 27 consecutive years.
What is IDXX's earnings growth rate?
IDXX compound annual EPS growth rates (CAGR): 1-Year: +22.6%, 3-Year: +17.7%, 5-Year: +14.3%, 10-Year: +20.4%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1991 to 2025.
What are IDXX's profit margins?
IDEXX Laboratories, Inc. net profit margin is +24.6%, operating margin is +31.6%, and gross margin is +61.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +66.2%.
Is IDXX growing earnings?
Yes, IDXX earnings are accelerating — EPS growth of +22.6% exceeds the 5-year CAGR of +14.3%. TTM net income reached $1.1B. Earnings momentum is strengthening.
What was IDXX's best earnings year?
IDEXX Laboratories, Inc.'s highest annual net income on record is $1.1B, achieved in fiscal year 2025. Earnings history on this page spans 1991 to 2025 and includes all annual and quarterly figures.
What were IDXX's earnings last quarter?
IDXX's most recent reported quarter was Q1 2026. Net income was $278M with diluted EPS of $3.45. For a full breakdown of all quarters, see the quarterly earnings table on this page.